From fragment to clinical candidate—a historical perspective
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference60 articles.
1. A brief history of novel drug discovery technologies;Gershell;Nat. Rev. Drug Discov.,2003
2. Natural products in drug discovery;Harvey;Drug Discov. Today,2008
3. High-throughput screening: new technology for the 21st century;Hertzberg;Curr. Opin. Chem. Biol.,2000
4. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?;Newman;J. Med. Chem.,2008
5. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998–2006;Houston;Drug Discov. Today,2008
Cited by 185 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of the Commercially Available Chemical Space for Using in the 19F NMR FAXS Method: a Enamine Ltd. Case;Journal of Organic and Pharmaceutical Chemistry;2023-08-21
2. Fragment-based Ligand Discovery (FBLD);The Handbook of Medicinal Chemistry;2023-02-03
3. KID: A Kinase-Focused Interaction Database and Its Application in the Construction of Kinase-Focused Molecule Databases;Journal of Chemical Information and Modeling;2022-11-30
4. Screening and Characterizing of GPCR –Ligand Interactions with Mass Spectrometry‐Based Technologies;GPCRs as Therapeutic Targets;2022-09-16
5. Absorbing knowledge from an emerging field: The role of interfacing by proponents in big pharma;Technovation;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3